UroGen Pharma
URGN
URGN
43 hedge funds and large institutions have $454M invested in UroGen Pharma in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
8.16% more ownership
Funds ownership: 51.88% → 60.04% (+8.2%)
5% more funds holding
Funds holding: 41 → 43 (+2)
Holders
43
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$26.6M | |
| 2 | +$20.9M | |
| 3 | +$20M | |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$13.9M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$11.4M |
Top Sellers
| 1 | -$7.41M | |
| 2 | -$2.63M | |
| 3 | -$1.77M | |
| 4 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$1.18M |
| 5 |
HCM
Highline Capital Management
New York
|
-$1.15M |